In the U.S., many people with diagnosed or probable chronic obstructive pulmonary disease (COPD) at higher risk of disease exacerbations are not receiving recommended care, a new study found. “This analysis reveals the gaps and opportunities for improvement in the identification and management of patients with COPD in the…
Read more
As we go through life, we face many changes. Some are happy, like the birth of a child or the accomplishment of a goal, while others, like illness and physical limitations, are harder to embrace. Such experiences are on my mind because I’m preparing for my yearly wellness check. In…
Increases in new onset or recurring depression were seen among older Canadian adults with chronic obstructive pulmonary disease (COPD) during the early stages of the COVID-19 pandemic, a study shows. One in six patients without a history of depression before the pandemic developed it early on in it. For…
Several months ago, I was selected by the pharmaceutical company Sanofi to be screened for a clinical trial called AERIFY-1. The study, which is being conducted by the global research company Care Access, aims to assess the efficacy, safety, and tolerability of the investigational therapy itepekimab in…
After a lengthy screening process for a COPD clinical trial, columnist Caroline Gainer learned she didn’t qualify — but for a good reason.
In this podcast series, pulmonary specialist Dr. Noah Greenspan discusses topics related to pulmonary diseases, including COPD.
COPD is a chronic inflammatory disease of the lungs, in which the airways become blocked, causing cough with mucus, wheezing, and shortness of breath.
The causes of COPD are not fully understood. However, long-term exposure to lung irritants is known to damage the lungs and the airways.
Some people may also experience exacerbations, or episodes of sudden disease worsening, that may persist for several days.
Get regular updates to your inbox.